Oral Sodium Chloride Dosing for Hyponatremia
For mild-to-moderate symptomatic hyponatremia or SIADH not responding to fluid restriction, oral sodium chloride tablets should be dosed at 100 mEq (approximately 6 grams) three times daily (TID), which can be administered as salt tablets or concentrated oral solution. 1
Dosing Regimens by Clinical Context
For SIADH (Mild Symptoms or Asymptomatic)
- Standard dose: 100 mEq (6 grams) PO TID 1
- This is used when patients fail initial fluid restriction (1 L/day)
- Combine with continued fluid restriction and high-protein diet
- Monitor serum sodium daily initially
For Cerebral Salt Wasting (CSW)
- Oral salt tablets are used as adjunctive therapy alongside IV normal saline and fludrocortisone 1
- Dosing follows similar principles but requires more aggressive volume replacement
- Salt supplementation continues for 7 days with fludrocortisone
Alternative Hourly Dosing Strategy
For patients requiring more controlled correction but unable to receive IV hypertonic saline:
- Calculate dose to deliver equivalent of 0.5 mL/kg/hour of 3% NaCl 2
- Administer hourly with close monitoring (every 2-4 hours)
- This approach provides predictable, graded increases in serum sodium
- Target correction: 6 mEq/L over 6 hours for severe symptoms
FDA-Approved Concentrated Oral Solution
Sodium Chloride 23.4% Oral Solution (4 mEq/mL):
- Standard adult dose (ages 9-50): 4 mL (equivalent to 936 mg or 16 mEq) 3
- Children under 9 and adults over 50: Requires physician consultation for dosing
- Each 4 mL provides 368 mg elemental sodium (25% daily value)
- Available in 473 mL bottles (approximately 118 servings)
Important note: The FDA-labeled dose of 4 mL (16 mEq) represents a single serving for maintenance, not acute treatment. For therapeutic hyponatremia management per neurosurgical guidelines, the 100 mEq TID dosing (approximately 25 mL TID of 23.4% solution) is appropriate.
Correction Rate Limits (Critical Safety Parameters)
Never exceed these limits to prevent osmotic demyelination syndrome:
- Maximum correction: 8 mmol/L in first 24 hours 1
- For acute symptomatic hyponatremia: Correct 6 mmol/L over 6 hours, then limit additional correction to 2 mmol/L over remaining 18 hours
- High-risk patients (alcoholism, malnutrition, liver disease, severe hyponatremia ≤105 mmol/L): Limit to 8 mmol/L per 24 hours 4
- Standard patients: Maximum 10-12 mmol/L per 24 hours 4, 5
Monitoring Requirements
Frequency based on severity:
- Severe symptoms (mental status changes, seizures): Every 2 hours 1
- Mild symptoms: Every 4 hours 1
- Asymptomatic: Daily 1
- Also monitor: Daily weights, intake/output, urine sodium
Clinical Context Matters
The neurosurgical guidelines 1 provide the most specific oral salt tablet dosing (100 mEq TID), particularly for SIADH management. This contrasts with the FDA-labeled "maintenance" dose of 16 mEq per serving 3, which is insufficient for therapeutic correction of hyponatremia.
Key distinction: Oral salt tablets are second-line therapy for SIADH when fluid restriction fails, but they should NOT be used as primary therapy for severe symptomatic hyponatremia requiring ICU-level care with IV hypertonic saline 1. The hourly oral dosing strategy 2 offers a middle ground when IV access or ICU transfer is unavailable, but requires intensive monitoring.
Common Pitfalls to Avoid
- Do not use oral salt tablets for severe symptomatic hyponatremia (seizures, coma) - these patients require IV 3% NaCl 1
- Do not confuse maintenance dosing with therapeutic dosing - FDA label shows maintenance, not acute treatment doses
- Do not use in CSW without concurrent volume replacement - salt alone worsens volume depletion 1
- Never rapidly correct chronic hyponatremia - risk of osmotic demyelination increases dramatically 1, 4